SB 1389 prohibits healthcare providers participating in Tennessee's TennCare or CoverKids programs from refusing to treat patients solely because they decline vaccines or immunizations. It requires the state to stop reimbursing providers who violate this rule and mandates the TennCare director to create implementing regulations. The law excludes oncology and organ transplant specialists from the prohibition. The bill takes effect July 1, 2025, with rules to be established under state administrative procedures.
SB 440 clarifies that standalone dental and vision insurance plans (known as "excepted benefits") are not required to cover specific medical treatments, services, or conditions unless state law explicitly mandates it. This change directly affects health insurance plans offering these stand-alone benefits, removing an implied obligation to cover certain medical needs under those plans. The law applies to all new or renewed insurance policies issued on or after July 1, 2025, ensuring clarity for insurers and policyholders. It does not alter existing coverage requirements for standard health insurance plans.
SB 1146 requires county medical examiners to test decedents involved in mass shootings (resulting in four or more deaths) for all drugs, including psychotropic medications used for mental health conditions. It mandates anonymized data sharing with the University of Tennessee Health Science Center and the Department of Health, prohibiting disclosure of identifying information. The health science center must study drug interactions and submit quarterly reports to legislative health committees. The law, effective July 1, 2025, applies to medical examiners, health agencies, and the University of Tennessee, while requiring compliance with privacy laws.
SB 955, now known as the "Medical Ethics Defense Act," protects Tennessee healthcare providers from being forced to participate in or pay for medical procedures that conflict with their conscience. It defines "conscience" as sincerely held ethical, moral, or religious beliefs and prohibits discriminatory actions - like termination or penalties - against providers who refuse specific procedures based on those beliefs. The law also safeguards providers who report violations of this act, preventing retaliation for whistleblowing. This applies to healthcare professionals, institutions, and payers but excludes procedures governed by federal law (such as emergency care under EMTALA).
HB 1198 requires Tennessee health insurers and TennCare to allow patients to try biosimilar drugs (cost-effective copies of brand-name medications) before covering the original branded drug. It amends state law to permit health carriers to mandate a biosimilar trial for equivalent branded prescriptions, removing prior requirements for generic drug trials. The bill also directs TennCare’s pharmacy committee to consider biosimilar drugs when recommending medications for the state’s preferred drug list. These changes aim to reduce prescription drug costs by increasing biosimilar adoption, as stated in the bill’s legislative findings.
SB 515 extends Tennessee's current limit of 125 new nursing home beds per fiscal year for which the health facilities commission may approve (via certificate of need) until June 30, 2029, instead of expiring in 2025. This directly affects nursing home facilities seeking to expand and the health facilities commission, which reviews and approves new bed applications. The key provision is a simple extension of the existing cap, not a change to the 125-bed limit. The bill became effective March 25, 2025, after being signed by the Governor.
SB 1063 removes two notification requirements related to prior authorization for healthcare services in Tennessee. It eliminates the requirement for healthcare providers to notify patients when communicating with insurance companies about missing information for prior authorization, and it removes the requirement for insurance companies to notify patients when additional information is needed from the patient or provider. The bill directly affects healthcare providers, insurance companies, and patients by reducing administrative steps in the prior authorization process. These changes amend Tennessee Code sections 63-1-171 and 56-6-705, effective April 3, 2025.
SB 577 amends Tennessee's TennCare program by shortening the time frame for implementing the annual coverage assessment from seven days to five days. It also establishes limits on hospital payments under specific circumstances, directly affecting TennCare administrators and participating hospitals. The bill changes the timing requirement in Tennessee Code Annotated Section 71-5-2005(d)(2)(D) and became effective April 3, 2025, after being signed by the Governor.
HB 1157, the "Restore Trust in Public Health Messaging Act," requires Tennessee's Department of Health, local health departments, and state executive branch to ensure all public communications about FDA-regulated products (like medications) accurately reflect the FDA-approved or FDA-authorized labels. It prohibits promoting information that conflicts with these labels, including general product categories unless universally true or properly qualified. The law mandates an internal compliance review by July 2025, annual reporting to state officials starting in 2026, and a complaint process for violations with potential penalties. This directly affects state health agencies' public messaging about medical products, aiming to align communications with federal FDA standards.
